GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Selling and Marketing Expense

LTR Pharma (ASX:LTP) Selling and Marketing Expense : A$ Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. LTR Pharma's Selling and Marketing Expense for the six months ended in Jun. 2023 was A$0.00 Mil. LTR Pharma does not have enough years/quarters to calculate the Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023.

LTR Pharma Selling and Marketing Expense Historical Data

The historical data trend for LTR Pharma's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Selling and Marketing Expense Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Selling and Marketing Expense
- - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Selling and Marketing Expense - - -

LTR Pharma Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

LTR Pharma Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Selling and Marketing Expense
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines